Having assessed the discordance rate of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis, our study demonstrated no significant difference between discordance and concordance groups. The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.